Display options
Cite
Aggeli C, Polytarchou K, Varvarousis D, et al. Stress ECHO beyond coronary artery disease. Is it the holy grail of cardiovascular imaging?. Clin Cardiol. 2018;41(12):1600-1610doi: 10.1002/clc.23094.
Aggeli, C., Polytarchou, K., Varvarousis, D., Kastellanos, S., & Tousoulis, D. (2018). Stress ECHO beyond coronary artery disease. Is it the holy grail of cardiovascular imaging?. Clinical cardiology, 41(12), 1600-1610. https://doi.org/10.1002/clc.23094
Aggeli, Constantina, et al. "Stress ECHO beyond coronary artery disease. Is it the holy grail of cardiovascular imaging?." Clinical cardiology vol. 41,12 (2018): 1600-1610. doi: https://doi.org/10.1002/clc.23094
Aggeli C, Polytarchou K, Varvarousis D, Kastellanos S, Tousoulis D. Stress ECHO beyond coronary artery disease. Is it the holy grail of cardiovascular imaging?. Clin Cardiol. 2018 Dec;41(12):1600-1610. doi: 10.1002/clc.23094. Epub 2018 Nov 24. PMID: 30315566; PMCID: PMC6489791.
Copy Download .nbib Format: NLM
Share it on

Clin Cardiol. 2018 Dec;41(12):1600-1610. doi: 10.1002/clc.23094. Epub 2018 Nov 24.

Stress ECHO beyond coronary artery disease. Is it the holy grail of cardiovascular imaging?.

Clinical cardiology

Constantina Aggeli, Kali Polytarchou, Dimitrios Varvarousis, Stellios Kastellanos, Dimitrios Tousoulis

Affiliations

  1. 1st Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  2. 1st Department of Cardiology, Evagelismos General Hospital of Athens, Athens, Greece.
  3. 2nd Department of Cardiology, General Hospital of Nikea-Piraeus "Agios Panteleimon", Piraeus, Greece.

PMID: 30315566 PMCID: PMC6489791 DOI: 10.1002/clc.23094

Abstract

Stress echocardiography (SE) is a very useful method in clinical practice, because it offers important information of both the patient's functional status and hemodynamic changes during stress. Therefore, SE provides strong diagnostic and prognostic data in a wide spectrum of cardiovascular diseases. This review summarizes the clinical applications of SE in conditions beyond coronary artery disease (CAD) and highlights practical recommendations and key issues for each condition that need further investigation. SE is an established method for the evaluation of symptomatic and asymptomatic patients with valvular heart disease (VHD) and cardiomyopathies, and provides important information regarding prognosis and management of patients with congenital heart disease, pulmonary hypertension or diastolic dysfunction. Moreover, when one or multiple VHD and cardiomyopathy or CAD coexist in one patient, SE is a very useful clinical tool for the evaluation of etiology and symptomatology.

© 2018 Wiley Periodicals, Inc.

Keywords: cardiomyopathy; heart failure; mitral stenosis; pulmonary hypertension; stress echocardiography; valvular heart disease

References

  1. Circ Cardiovasc Imaging. 2017 Apr;10(4): - PubMed
  2. Circ Cardiovasc Imaging. 2014 Mar;7(2):352-62 - PubMed
  3. Clin Cardiol. 2018 Dec;41(12):1600-1610 - PubMed
  4. Echocardiography. 2015 Mar;32(3):490-5 - PubMed
  5. J Am Soc Echocardiogr. 2015 Sep;28(9):1036-44 - PubMed
  6. J Am Coll Cardiol. 2001 May;37(6):1685-91 - PubMed
  7. Eur Heart J Cardiovasc Imaging. 2015 Apr;16(4):353 - PubMed
  8. Eur Heart J. 2009 Feb;30(3):278-89 - PubMed
  9. Echocardiography. 2017 Mar;34(3):429-435 - PubMed
  10. Scand Cardiovasc J. 2014 Feb;48(1):4-12 - PubMed
  11. Echo Res Pract. 2016 Dec;3(4):R45-R55 - PubMed
  12. J Am Soc Echocardiogr. 2010 May;23(5):523-30 - PubMed
  13. Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):604-10 - PubMed
  14. PLoS One. 2012;7(9):e45265 - PubMed
  15. Circulation. 2003 Nov 11;108(19):2336-41 - PubMed
  16. J Am Soc Echocardiogr. 2008 Mar;21(3):246-50 - PubMed
  17. J Heart Lung Transplant. 2010 Aug;29(8):914-56 - PubMed
  18. J Am Heart Assoc. 2016 Jan 25;5(1): - PubMed
  19. JACC Cardiovasc Imaging. 2015 Jan;8(1):83-99 - PubMed
  20. Echocardiography. 2014 Mar;31(3):347-52 - PubMed
  21. Eur Heart J. 2017 Sep 21;38(36):2739-2791 - PubMed
  22. Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):647-653 - PubMed
  23. Eur Heart J. 2016 Jan 1;37(1):67-119 - PubMed
  24. Int J Cardiol. 2017 Sep 15;243:290-295 - PubMed
  25. J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185 - PubMed
  26. Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1191-1229 - PubMed
  27. Curr Treat Options Cardiovasc Med. 2017 Mar;19(3):17 - PubMed
  28. Am J Cardiol. 1992 Feb 1;69(4):367-72 - PubMed
  29. Eur J Heart Fail. 2014 Dec;16(12):1345-61 - PubMed
  30. Heart. 2011 Feb;97(4):272-7 - PubMed
  31. Curr Treat Options Cardiovasc Med. 2017 Jul;19(7):54 - PubMed
  32. Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360 - PubMed
  33. J Am Soc Echocardiogr. 2017 Sep;30(9):829-844 - PubMed
  34. J Am Soc Echocardiogr. 2005 Nov;18(11):1149-54 - PubMed
  35. Eur Heart J. 2014 Oct 14;35(39):2733-79 - PubMed
  36. Curr Treat Options Cardiovasc Med. 2015 May;17(5):378 - PubMed
  37. Eur Heart J Cardiovasc Imaging. 2017 Nov 1;18(11):1278-1282 - PubMed
  38. Curr Cardiol Rep. 2015 Jun;17(6):42 - PubMed
  39. Int J Cardiol. 2006 Jul 28;111(1):120-6 - PubMed
  40. J Am Coll Cardiol. 2008 Dec 2;52(23):e143-e263 - PubMed
  41. Circ Cardiovasc Imaging. 2013 Sep;6(5):840-9 - PubMed

MeSH terms

Publication Types